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Expression of Axl, a receptor tyrosine kinase, is increased in cutaneous squamous cell carcinoma (SCC).
Examination of a series of cutaneous SCC tumors revealed positive phospho-Akt (P-Akt) staining accompanied
by weak TUNEL staining in Axl-positive tumors, suggesting an anti-apoptotic role for Axl in SCC survival. The
role of Axl in UV-induced apoptosis was investigated in a cutaneous SCC cell line using retroviral short hairpin
RNA sequences enabling stable Axl knock-down. We show that, although Axl knock-down has no effect on cell
proliferation, it sensitizes cells to UV-induced apoptosis through increased activation of the pro-apoptotic
protein Bad, a change in the conformation of Bax and Bak, release of cytochrome c into the cytosol, and
activation of caspases. These events are accompanied by faster Akt dephosphorylation in UV-treated Axl knock-
down cells and correlate with the degree of Axl knock-down. Treatment with the pan-caspase inhibitor zVAD-
fmk partially rescued cells from UV-induced apoptosis but did not affect Bid cleavage or cytochrome c release,
suggesting that cells die via the mitochondrial-mediated pathway. Thus, Axl confers resistance of SCC cells to
apoptosis and displays potential as a target for therapeutic intervention in cutaneous SCC.
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INTRODUCTION
Squamous cell carcinoma (SCC) accounts for approximately
20% of all cutaneous malignancies and occurs on UV-
exposed body sites (Diepgen and Mahler, 2002). About 4% of
cutaneous SCCs metastasize (Brantsch et al., 2008) and these
patients have a 5-year survival of 25%, highlighting the need
to improve therapy.
We recently reported that expression of the receptor
tyrosine kinase, Axl, is upregulated in SCC skin tumors in vivo
(Green et al., 2006). Overexpression of Axl has been
associated with invasion and metastasis in various cancers
(Meric et al., 2002; Sainaghi et al., 2005; Lay et al., 2007;
Sawabu et al., 2007). Axl, in conjunction with its ligand,
growth arrest-specific gene 6 (Gas6), can enhance cell
survival. Recent data have shown that Axl signaling can
prolong malignant glioma growth in mouse brain (Vajkoczy
et al., 2006).
Following a cell death signal, a number of apoptotic
factors, including cytochrome c, are released from the
mitochondrial intermembrane space into the cytosol, by a
mechanism that allows selective permeabilization of the
outer mitochondrial membrane (OMM) (Kluck et al., 1997).
The anti-apoptotic proteins, Bcl-2, Bcl-XL, and Mcl-1,
antagonize the release of cytochrome c from the mitochon-
dria and subsequent caspase activation, whereas the pro-
apoptotic proteins, Bax and Bak, promote apoptosis (Wei
et al., 2001). Inhibitory molecules, such as Bad, bind to anti-
apoptotic Bcl-2/Bcl-XL proteins, thereby preventing their
sequestration of molecules such as cleaved Bid (tBid) or
Bim that can directly activate Bax and Bak (Letai et al., 2002;
Kuwana and Newmeyer, 2003; Kim et al., 2006).
Immunohistochemical analysis revealed increased phos-
pho-Akt (P-Akt) staining with significantly lower TUNEL
staining in Axl-positive tumors and led us to examine the
mechanisms by which Axl regulates apoptosis in cutaneous
SCC cells. Retroviral gene delivery of Axl-targeting short
hairpin RNA (shRNA) sequences was used to achieve
stable Axl knock-down. Our results demonstrate that Axl
contributes to the malignant SCC phenotype by protecting
cells from UV-induced apoptosis through modulation of the
Akt and associated PTEN pathways and suppression of the
pro-apoptotic activity of Bcl-2 family members.
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RESULTS
Negative correlation between Axl protein expression and
apoptosis in cutaneous SCC tumors
As Axl has been reported to signal via Akt in various cancers,
thereby protecting them from apoptosis, we hypothesized
that there may be a correlation between Axl, P-Akt, and
apoptosis in cutaneous SCC tumors. Sections from 15 SCCs
were scored for staining intensity between 0 (no staining) and
3 (intense staining). In contrast to normal skin, which
expresses minimal P-Akt, 11/15 (73%) SCCs exhibited P-Akt
staining. Axl staining was detected in 10/15 (67%) SCCs,
whereas 6/15 (40%) SCCs showed apoptotic cells detected by
TUNEL staining. Staining for P-Akt was strong in Axl-positive
tumors and was accompanied by significantly decreased
TUNEL staining, whereas Axl-negative tumors exhibited
weak P-Akt and strong TUNEL staining (Figure 1a). Samples
were subdivided into positive (2–3) and weak or negative
(0–1) Axl staining for analysis. Median values (bars±SD)
on the graph correspond to P-Akt or TUNEL staining in the
Axl-positive and -negative tumors (Figure 1b). There was no
correlation between Axl expression and differentiation status.
Knock-down of Axl sensitizes MET1 SCC cells to UV-induced
apoptosis
In order to investigate the role of Axl in apoptosis, sustained
Axl knock-down was achieved in MET1 SCC cells using
shRNA sequences 1053 and 2833. Immunoblotting of total
cell lysates from 1053- and 2833-transduced cells revealed a
49% and 92% mean Axl knock-down, respectively (Figure
2a), without any effect on cell proliferation (Figure 2b).
Mitochondrial apoptosis involves activation of caspase 3,
which is responsible for proteolytic cleavage of the nuclear
enzyme poly(ADP-ribose) polymerase (PARP) to bring about
cell disassembly (Kaufmann et al., 1993). Immunoblotting
showed that treatment with UV up to 24 hours resulted
in a small fluctuation of Axl expression levels (Figure 2c),
which varied between replicate experiments. Moreover, we
observed greater cleavage of caspase 3 and PARP in Axl
knock-down compared with pSUPERIOR.retro.puro vector
(pSup) cells (Figure 2c). Findings were replicated in a second
cell line, SCC-IC 1 (see Supplementary Figure S1 online).
Apoptosis increased over time, so that 24 hours after UV
treatment there were 17% pSup, 27% 1053, and 50% 2833
apoptotic cells (Figure 2d). Thus, abrogation of Axl expres-
sion leads to increased sensitivity to UV-induced apoptosis,
correlating with the degree of Axl knock-down.
Knock-down of Axl increases basal phosphorylation of PTEN
and the pro-apoptotic potential of Bad
We next investigated the effect of Axl knock-down on Akt
and associated pathways in SCC cells. Immunoblotting
showed a pronounced time-dependent decrease in Akt
phosphorylation in response to UV treatment, which was
proportional to the degree of Axl knock-down, whereas total
Akt levels remained unchanged (Figure 3a). A downstream
Akt target that has a critical role in mediating apoptosis is the
pro-apoptotic protein Bad (Zha et al., 1996; Datta et al.,
1997). Total levels of Bad expression remained largely
unchanged by UV treatment, whereas there was a greater
decline in the phosphorylation of Bad in 2833 MET1 cells
(Figure 3a). Dephosphorylation of PTEN, a key tumor
suppressor, at the C-terminal tail, decreases its stability while
enhancing its function as an antagonist of PI3K/Akt signaling
(Stambolic et al., 1998; Vazquez et al., 2000). Immunoblot-
ting revealed that knock-down of Axl enhanced basal
phosphorylation of phospho-PTEN. In addition, a greater
decrease in the total expression levels of PTEN was observed
over the time course of UV treatment in Axl knock-down cells
(Figure 3a). In order to verify the role of Akt in modulating
resistance to apoptosis, MET1 cells were pre-treated with
SH5, a selective inhibitor of Akt activity (Figure 3b). This
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Figure 1. Correlation between Axl, P-Akt, and TUNEL staining in a series of
SCC tumors. (a) Staining for P-Akt and TUNEL in Axl-positive and -negative
SCC tumors. (b) Around 15 tumors were stained for Axl, P-Akt, and TUNEL.
The intensity of staining was scored from 0 (no staining) to 3 (intense staining).
Samples were subdivided into positive (2–3) and weak or negative (0–1) Axl
staining. Median values (bars±SD) on the graph correspond to P-Akt or
TUNEL staining in the positive and negative cells. **Po0.01. Bar¼100 mm.
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resulted in a significant increase in apoptosis 16 hours after
treatment with UV, which correlated with the degree of Axl
knock-down, suggesting that Axl functions via Akt to protect
SCC cells from apoptosis (Figure 3c).
Knock-down of Axl enhanced UV-induced activation of Bax and
Bak in MET1 cells
The pro-apoptotic proteins Bax and Bak regulate mitochon-
drial cytochrome c release through the formation of pores in
the OMM (Wei et al., 2001), while Bcl-2, Bcl-XL, and Mcl-1
are antagonists of Bax and Bak activation (Kim et al., 2006).
Immunoblotting showed no change in Bcl-2 or Bcl-XL
expression and Mcl-1 was degraded equally in response to
UV treatment in both Axl knock-down and pSup cells (Figure
4a), indicating its dissociation from Bak, which is known to
trigger apoptosis (Nijhawan et al., 2003). Although expres-
sion levels of Bak remained relatively unaltered, there was an
increase in the expression of Bax over the time course of
UV treatment (Figure 4a). Activation of Bax and Bak was
examined by conformation-specific monoclonal antibodies.
Axl knock-down cells exhibited greater Bak and Bax activities
compared with pSup cells, proportional to the degree of Axl
knock-down, in response to UV with maximal activation at
16 hours (Figure 4b and c). We next examined the transloca-
tion of active monomeric Bax from the cytosol to the
mitochondria by confocal microscopy. Results showed
that movement of Bax to the mitochondria (yellow staining)
occurred within 6 hours of UV treatment and was greater in
2833 compared with pSup cells (Figure 4d). These data show
that knock-down of Axl in MET1 SCC cells results in a change
in the conformation of Bak and Bax in response to UV
treatment.
Increased cytochrome c release in the cytosol of UV-treated Axl
knock-down cells
To measure mitochondrial membrane potential (Dcm), cells
were stained with the potential-sensitive dye tetramethylrho-
damine ethyl ester perchlorate (TMRE) and 4,6-diamidino-2-
phenylidole (DAPI) before FACS processing; DAPI-positive
cells were gated out for the analysis. Treatments with NaNO3
or CCCP were used as positive controls. An almost equal
drop in Dcm of approximately 30% was observed as early
as 16 hours after UV treatment in all cells (Figure 5a).
To examine cytochrome c release into the cytosol, cells
were permeabilized with a hypertonic digitonin-containing
solution. Immunoblotting exhibited a greater cytochrome c
release in the cytosol of Axl knock-down compared with
pSup cells (Figure 5b). These results show that although
knock-down of Axl does not seem to affect Dcm, it results in
cytochrome c release into the cytosol in a regulated way.
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Figure 2. Axl knock-down renders MET1 cells susceptible to apoptosis. (a) Axl expression was analyzed by immunoblot of cell lysates from MET1 cells
transduced with pSup vector alone or Axl-targeting shRNA sequences 1053 or 2833 (irrelevant lanes between pSup and 1053 were removed). (b) Cell
proliferation was assessed by counting cells using trypan blue exclusion at the indicated times. Data shown are from three independent experiments.
(c) pSup, 1053, and 2833 cells were exposed to UV (20mJ cm2) and expression levels of Axl, caspase 3, and PARP were detected in cell lysates by
immunoblotting. Tubulin was used as a loading control. The data are representative of three independent experiments. (d) Apoptosis was quantified by Annexin
V-FITC/PI staining of pSup, 1053, and 2833 cells treated with UV for the indicated times. (i) Scatter plots from one experiment are shown; (ii) data (mean±SEM)
from two experiments expressed as % Annexin-V-positive cells are shown. C, cleaved; N, native. **Po0.01, ***Po0.001.
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Axl knock-down enhances caspase activation and leads to
caspase-dependent apoptosis
To further determine the role of Axl in apoptosis following
cytochrome c release, the activities of caspases 3 and 8 were
measured in response to UV. Data revealed that caspase 3
activity in pSup, 1053, and 2833 cells increased by 4.0-, 6.5-,
and 8.0-fold, respectively, after 24 hours of UV treatment
(Figure 6a). Similarly, caspase 8 activity increased by
2.5-, 4.0-, and 5.6-fold in pSup, 1053, and 2833, respectively
(Figure 6b). Activity of both was completely blocked when
cells were treated with UV for 24 hours in the presence of
the pan-caspase inhibitor zVAD-fmk (Figure 6a and b). These
results indicate that UV-induced caspase activation increases
with the degree of Axl knock-down. Next, MET1 cells were
treated with UV in the presence of zVAD-fmk and apoptotic
cells were quantified by Annexin V-FITC/PI staining. Our data
show that UV-induced cell death is partly caspase dependent
(Figure 6c).
Knock-down of Axl affects expression levels of Bid
Bid is a key pro-apoptotic BH3-only molecule linking the
receptor- and mitochondria-mediated apoptotic pathways.
Cleavage and activation of native p22 Bid by caspase 8
results in the generation of p15 tBid, which has a role in the
activation of Bax and Bak and cytochrome c release (Luo
et al., 1998). Immunoblotting of total cell lysates revealed a
striking decrease in the basal expression levels of Bid, which
was proportionate to the degree of Axl inhibition in MET1
cells (Figure 6d). However, levels of tBid were similar in Axl
knock-down and pSup cells 24 hours after treatment with UV
(Figure 6d). Thus, although Axl seems to have a role in
modulating Bid expression, it does not seem to affect Bid
processing. As an increase in caspase 8 activity was observed
in response to UV treatment in MET1 cells (Figure 6b), we
wanted to clarify the role of Bid in UV-induced death in SCC
cells. Immunoblot analysis revealed that although treatment
with zVAD-fmk inhibited proteolytic processing of Bid, it did
not affect the amount of cytochrome c released in response to
UV (Figure 6e). Inhibition of Bid expression using transient
small interfering RNA (siRNA) transfection (Figure 6f)
exhibited no significant change in UV-induced apoptosis
(Figure 6f). These data indicate that cytochrome c release
occurs upstream of caspase activation, whereas proteolytic
processing of Bid appears to be a downstream event.
DISCUSSION
A major feature of SCC cells is their resistance to apoptosis
(Erb et al., 2005). Immunohistochemical analysis of SCC
tumors revealed a correlation between Axl and P-Akt staining
with a reduction in TUNEL staining in Axl-positive tumors,
leading us to investigate further the mechanism by which Axl
promotes tumor cell survival. Knock-down of Axl in MET1
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Figure 3. Effect of Axl knock-down on the activation of Akt, Bad, and PTEN
in response to UV. (a) pSup, 1053, and 2833 MET1 cells were exposed to UV
(20mJ cm2) for the indicated times and expression levels of Akt, P-Akt Ser473,
Bad, P-Bad Ser136, PTEN, and P-PTEN Ser380 were detected in total cell lysates
by immunoblotting. Tubulin was used as a loading control. Bar graphs show
the fold change (mean±SD) in protein expression from two to three blots.
(b) Immunoblot analysis showing expression levels of Akt and P-Akt Ser473
after a dose–response treatment using the specific inhibitor of Akt activity
SH5. DMSO was used as a vehicle control, while GAPDH was used as a
loading control. (c) pSup, 1053, and 2833 MET1 cells were pre-treated with
SH5 (40 mM) for 1 hour and were subsequently treated with UV (20mJ cm2)
for 16 hours. Apoptosis was determined by calculating the ratio of caspase 3
activity over cellular ATP content (cell titer). Data (mean±SEM) are expressed
as fold change of respective controls. **Po0.01.
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SCC cells resulted in significantly greater caspase activity
and apoptosis in response to UV compared with control
cells. A previous study using a head and neck SCC cell line
demonstrated that one of the most significant repercussions
of deregulated Akt signaling is disruption of the apoptotic
response to UVB (Decraene et al., 2004). Knock-down of Axl
did not majorly affect total or phosphorylated basal levels of
Akt. However, Axl knock-down resulted in a pronounced loss
of UV-induced Akt phosphorylation and was accompanied
by dephosphorylation of the BH3-only protein Bad, which is
known to enhance the ability of Bad to antagonize Bcl-2 and
Bcl-XL anti-apoptotic activities (Zha et al., 1996; Datta et al.,
1997). Our findings are consistent with previous studies
showing that Axl functions via Akt to enhance cell survival
(Goruppi et al., 1999; Lee et al., 2002; Sawabu et al., 2007).
To further clarify the mechanism of Akt dephosphor-
lation, we focused on PTEN, a known antagonist of
Akt-dependent cell survival (Stambolic et al., 1998). Axl has
previously been shown to interact with C1-TEN, a PTEN
homolog (Hafizi et al., 2002); however, no association has
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been reported between Axl and PTEN. Interestingly, our
results revealed that knock-down of Axl markedly increased
basal PTEN phosphorylation and led to a decrease in total
PTEN levels in response to UV treatment. Recent studies
have reported that the activity of PTEN is related to its phos-
phorylation status at the C-terminal ‘‘tail’’, with depho-
sphorylation resulting in decreased protein stability with a
coincident increase in activity (Vazquez et al., 2000, 2001).
The increased phosphorylation of PTEN in the Axl knock-
down cells could explain the loss of Akt phosphorylation in
response to UV treatment, positioning Axl as a negative
regulator of PTEN activity.
We next investigated the effect of knocking down Axl on
the activities of Bax and Bak, two proteins that are required
for commitment to cell death (Wei et al., 2001). A change in
the conformation of Bax and Bak was detected within 6 hours
of UV treatment. This was accompanied by cytochrome c
release, which was greater in Axl knock-down cells. This
would imply that cytochrome c release takes place in a
regulated manner through the formation of specific channels
involving Bax and Bak and is negatively regulated by Axl.
Examination of anti-apoptotic proteins revealed that
consistent with previous studies (Nijhawan et al., 2003),
Mcl-1 was equally down-regulated in response to UV in pSup
and Axl knock-down cells. Contrary to a previous report
(Qin et al., 2006), UV treatment did not alter expression
levels of Bcl-2 and Bcl-XL in MET1 cells. In an attempt to
characterize further the mechanism by which Axl modulates
apoptosis, the expression of Bid, a crucial protein in the
crosstalk between receptor- and mitochondria-mediated
pathways, was examined. Basal expression of Bid was
reduced in Axl knock-down cells, suggesting that Axl may
have a role in regulating Bid stability. Bid cleavage became
evident after cytochrome c release had been detected and
was proportional to the degree of Axl knock-down. Addi-
tionally, inhibition of caspases blocked cleavage of Bid, but
did not affect cytochrome c release into the cytosol, indica-
ting it is unlikely for this process to have been driven by Bid
cleavage. Thus, cleavage of Bid likely occurs downstream of
Bax and Bak activation and is catalyzed by caspases. Contrary
to previous studies, which have described Bid cleavage as an
amplification step to the apoptotic process downstream of
cytochrome c release (Slee et al., 2000), our data using siRNA to
target Bid expression reveal a redundant role for Bid in UV-
induced cell death in accordance with previous studies
(Kaufmann et al., 2007). Our data suggest that SCC cells die
predominantly via the mitochondria-mediated pathway.
In summary, our data demonstrate that Axl controls the
relative balance between Akt and PTEN activities to modulate
the apoptotic response in cutaneous SCC through negative
regulation of Bak and Bak and to a lesser extent the BH3-only
protein Bad, providing a mechanism for the role of Axl in
cutaneous SCC resistance to apoptosis. Because Axl is located at
the cell membrane, successful inhibition of its activity will
potentially decrease downstream intracellular signaling and
impede tumor development without the risk associated with
intracellular feedback loops. The value of Axl as a therapeutic
target has been validated using potent Axl kinase inhibitors
that inhibited breast cancer cell motility and invasion (Zhang
et al., 2008). More recently, R428, a selective small-molecule
inhibitor of Axl, has been demonstrated to prolong survival
in animal models of metastatic breast cancer (Holland et al.,
2010). Our data support a role for Axl as a target for therapeutic
intervention in cutaneous SCC.
MATERIALS AND METHODS
Cell culture and treatments
Spontaneously immortalized SCC cells (MET1 and SCC-IC1) (Proby
et al., 2000; Martins et al., 2009) were cultured as described
previously (Rheinwald, 1980). The pan-caspase inhibitor zVAD-fmk
(Promega, Southampton, Hampshire, UK) or the Akt inhibitor SH5
(Enzo Life Sciences, Exeter, UK) was added to the media 1 hour
before UV stimulation and during treatment.
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Figure 6. Axl knock-down diminishes expression of Bid, a protein that has a redundant role in caspase-dependent cell death.MET1 pSup, 1053, and 2833 cells
were treated with UV for the indicated times in the presence or absence of zVAD-fmk (25 mM), and activities of (a) caspase 3 and (b) caspase 8 were quantified
by incubating total cell lysates with specific fluorogenic substrates. (c) Apoptosis was quantified by Annexin V-FITC/PI staining of pSup, 1053, and 2833 cells
treated or not with UV (20mJ cm2) and/or zVAD-fmk for 16 hours. Data (mean±SEM) shown are from three independent experiments. *Po0.05, **Po0.01.
(d) Cells were harvested after UV treatment and expression levels of full-length Bid and tBid were detected in total cell lysates by immunoblotting. (e) Cells were
pre-incubated with zVAD-fmk and were subsequently treated with UV for the indicated times. Cytosolic and total cytochrome c and total Bid levels were
examined by immunoblotting. (f) pSup, 1053, and 2833 MET1 cells were transiently transfected with Bid or non-targeting (NT) siRNA (50 nM) and immunoblot
analysis for Bid was carried out 96 hours post-transfection. Tubulin was used as a loading control. (g) BidsiRNA- or NTsiRNA-transfected MET1 cells were treated
with UV for 16 hours and apoptosis was determined by calculating the ratio of caspase 3 activity over cellular ATP content (cell titer). Data (mean±SEM) are
expressed as fold change of respective controls.
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RNA interference, retroviral generation and delivery
Oligonucleotides corresponding to different target sequences were
generated using OligoEngine RNAi Design Tool (Ambion, Huntingdon,
UK). shRNA target sequences are listed below with their starting
positions in the coding region of Axl: (1053) 50-GACATCCTC
TTTCTCCTGC-30 and (2833) 50-GATTTGGAGAACACACTGA-30.
Annealed oligonucleotides were cloned into pSup linearized by
BglII and HindIII downstream of the H1 promoter TATA box. pSup or
shRNA-containing plasmids were transfected into Phoenix packa-
ging cells (Orbigen, San Diego, CA) using FuGene 6 (Roche,
Welwyn Garden City, UK). At 2 days post transfection, cells were
incubated in DMEM supplemented with 10% fetal bovine serum,
2mM L-glutamine, and 1.25mgml1 puromycin. Puromycin-resistant
cells were maintained in selection media and were subcultured
when 80% confluent. Confluent cells were placed in a humidified
incubator at 32 1C for 12 hours to produce retrovirus-containing
supernatant, which was used to infect SCC cells as described (Akgul
et al., 2005). Transient cell transfections of non-targeting or Bid
ON-TARGETplus SMARTpool siRNA (50nM) sequences were per-
formed using Dharmafect as described previously (Martins et al., 2009).
UVB irradiation
The UVB source was a UVP Multiple Ray Lamp (Ultra-violet
Products, Cambridge, UK) (MRL-58 model) with emission at 302 nm,
which was calibrated before each experiment. Cells were then
replenished with fresh media.
Cell extracts and immunoblotting
Cells were lysed in Triton lysis buffer (TLB) as described previously
(Tournier et al., 2000). Cytosolic extracts were prepared using mannitol
buffer with digitonin (80mgml1) as described (Lee et al., 2006) and were
concentrated using Microcon Bioseparations centrifugal filters (Millipore,
Watford, UK). Protein content was normalized using a Bio-Rad DC assay.
Following SDS-PAGE, proteins were transferred onto a Hybond-P
membrane (Bio-Rad Laboratories, Hemel Hempstead, UK) using wet
transfer. Membranes were saturated in Tris-buffered saline, pH 7.6, with
0.1% Tween 20 (Sigma-Aldrich Company, Dorset, UK) and 5% non-fat-
dried milk (Marvel, Premier Foods, St Albans, UK). Antibodies against
Akt, P-Akt Ser473, AIF, Bad, caspase 3, PARP, Bcl-2, and Mcl-1 from Cell
Signalling Technology (Danvers, MA), Bcl-XL (H-62), Bax (P-19), Axl
(C-20), phospho-PTEN (P-PTEN) Ser380 and P-Bad Ser136 from Santa Cruz
Biotechnology (Santa Cruz, CA), PTEN from Millipore, Bid from R&D
Systems (Minneapolis, MN), cytochrome c from BD Biosciences (Oxford,
UK), Bak (Ab-1), tubulin from EMD Chemicals (Gibbstown, NJ) and
GAPDH from Abcam (Cambridge, UK) were used for immunodetection.
Secondary antibodies coupled to horseradish peroxidase were from
Dako. Signals were detected by ECLþ (GE Healthcare Life Sciences,
Buckinghamshire, UK). Densitometry was performed by ImageJ 1.41
and values were normalized to total protein and expressed as fold change.
FACS analysis
Apoptosis was detected using TACS Annexin V-FITC (R&D Systems).
Mitochondrial membrane depolarization was assessed by uptake of
TMRE (Invitrogen, Paisley, UK). Carbonyl cyanide 3-chlorophenyl-
hydrazone (CCCP, 100mM) and NaNO3 (1% v/v) were used as positive
controls. TMRE (40nM) was added to the media 30minutes before the
end of treatment and cells were trypsinized and washed with PBS. Cell
pellets were resuspended in HEPES (250mM) and DAPI (50ngml1) was
added 10minutes before FACS analysis. To assess activation of Bak, cells
were fixed with PBS/0.25% paraformaldehyde, harvested by scraping and
permeabilized with PBS/0.01% saponin. Cells were incubated with anti-
Bak Ab-1 mouse monoclonal antibody (1/50 dilution) and then phyco-
erythrin-conjugated (Dako, 500mg l1; 1/30 dilution) antibody while
mixing (4 1C, 30minutes). Mouse IgG was used as a negative control.
Analysis was performed with a Becton Dickinson LSRII flow cytometer
(BD Biosciences) using BD FACSDiva 6.0 software.
Caspase, viability, and proliferation assays
Activities of caspases 3 and 8 were measured fluorometrically using
Ac-DMQD-AMC or Ac-LETD-AFC substrates (Enzo Life Sciences)
following the manufacturer’s instructions. Substrate cleavage was
assessed by monitoring fluorescence intensity. Cell viability and
caspase 3 activity of cells grown in 96-well plates (30,000 cells per
well) were measured using CellTitre-Glo and Caspase-Glo 3/7 Lumines-
cent assays (Promega), respectively, according to the manufacturer’s
instructions. The intensity of fluorescence and luminescence was
measured using a Synergy 4 Multi-Mode Microplate Reader. The ratio
of caspase 3/7 activity over cellular ATP content (cell titer) was used as a
measure of apoptosis. Cell proliferation was determined by trypsinizing
and counting cells exhibiting trypan blue dye exclusion.
Immunoprecipitation
Protein A agarose Fast Flow beads (Upstate) were mixed with 2mg
anti-Bax 6A7 antibody (Sigma) on a rotating wheel (4 1C, 2 hours).
Antibody–bead complexes were washed thrice in TLB, combined
with pre-cleared cell lysates, and immunoprecipitated on a rotating
wheel (4 1C, overnight). Antigen–antibody complexes were washed
four times in TLB and the reaction was stopped by adding 6
Laemmli buffer and heating the samples (95 1C, 5minutes).
Histology and immunostaining
Archival paraffin blocks were used with ethics approval obtained from
the East London and City Health Authority Research Ethics Committee.
Expression of Axl and P-Akt Ser473 was examined using immunohisto-
chemistry on 4mm deparaffinized sections blocked with horse serum.
Immunostaining was performed as described previously (Jackson et al.,
2002). Apoptotic cells were detected in SCC sections by TUNEL assay
(Dead-End, Promega). Quantitative analysis of staining was performed
using KS400 version 3.0 imaging software (Carl Zeiss, Welwyn Garden
City, UK). Staining intensity was scored by counting cells in four repre-
sentative high-power fields, and was graded as 0 (no staining), 1 (weak),
2 (moderate), and 3 (intense). The anti-Bax 6A7 antibody was used to
detect active monomeric Bax in cells. Mitochondria were stained with
100nM mitotracker orange (Molecular Probes) for 30minutes in a
humidified atmosphere of 37 1C, 10% CO2, and 90% air. Acetone:
methanol (1:1)-fixed cells were blocked in PBS, 0.1% Triton X-100,
3% (w/v) bovine serum albumin, and incubated with primary (4 1C,
overnight) and AlexaFluor 488-conjugated (Molecular Probes) second-
ary antibodies (room temperature, 1hour). Nuclei were counterstained
with DAPI (1mgml1) and samples were mounted onto glass slides
using Immu-Mount (Thermo Fisher Scientific, Waltham, MA). Images
were captured using a Zeiss LSM 510 META laser-scanning microscope.
Statistical analysis
Statistical significance was determined by one-way analysis of
variance (ANOVA), with post hoc Tukey’s test for comparison
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between groups. Two-way ANOVA with Bonferroni correction for
comparison between replicate means was used for time-course
treatments.
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